Palladia is a veterinary-prescribed antineoplastic tablet for dogs containing toceranib phosphate. Designed for oral administration, it supports veterinarian-directed treatment plans requiring an antineoplastic option. Available in 10 mg, 15 mg, and 50 mg strengths, each bottle contains 30 tablets for convenient dosing flexibility. Palladia is a prescription dog medication in Canada and Quebec, with DINs assigned per strength.